Jeffery Horton
Family · Chipley, FLNPI 1396997193
Payments from drug & device makers
Across 159 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$879
- Novo Nordisk$341
- Merck$200
- Lilly USA, LLC$176
- AstraZeneca$161
- GSK$157
- plus $862 from 23 others
What the payments were for
- Food & beverage$2,775100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 53 | $879 |
| Novo Nordisk | 15 | $341 |
| Merck | 11 | $200 |
| Lilly USA, LLC | 15 | $176 |
| AstraZeneca | 10 | $161 |
| GSK | 11 | $157 |
| Novartis | 9 | $145 |
| Boehringer Ingelheim | 3 | $75 |
| Johnson & Johnson | 4 | $68 |
| Pfizer | 3 | $64 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Jazz Pharmaceuticals Inc. | 2 | $43 |
| Bayer | 2 | $40 |
| Dexcom, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Esperion Therapeutics, Inc. | 1 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Exact Sciences | 2 | $31 |
| Lundbeck LLC | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Impel Pharmaceuticals Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Eisai Inc. | 1 | $16 |
| Amgen | 1 | $12 |
How this compares
$2,775 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 99 | $111,739 |
| OzempicSemaglutide | 57 | $68,202 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 45 | $51,005 |
| LinzessLinaclotide | 56 | $36,714 |
| JardianceEmpagliflozin | 23 | $32,076 |
| XareltoRivaroxaban | 51 | $30,129 |
| FarxigaDapagliflozin Propanediol | 32 | $26,628 |
| EliquisApixaban | 37 | $23,868 |
| CaplytaLumateperone Tosylate | 11 | $20,978 |
| JanuviaSitagliptin Phosphate | 11 | $18,187 |
| TradjentaLinagliptin | 21 | $16,781 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $10,244 |
| Victoza 3-PakLiraglutide | 12 | $10,011 |
| SymbicortBudesonide/Formoterol Fumarate | 27 | $7,226 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 221 | $6,771 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $176 | $111,73999 claims |
| Novo NordiskOzempic | $341 | $68,20257 claims |
| GSKTrelegy Ellipta | $157 | $51,00545 claims |
| Boehringer IngelheimJardiance, Tradjenta | $75 | $48,85744 claims |
| AbbVieLinzess | $879 | $36,71456 claims |
| AstraZenecaFarxiga, Symbicort | $161 | $33,85459 claims |
| Johnson & JohnsonXarelto | $68 | $30,12951 claims |
| PfizerEliquis, Premarin | $64 | $27,79573 claims |
| MerckJanuvia | $200 | $18,18711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 14,618 family providers in Florida.
Other family in Chipley
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.